SEOUL, Jan. 14 (Korea Bizwire) — South Korea and Britain will hold working-level talks next week to chart their future partnership after British parliamentarians’ vote this week on their government’s deal to leave the European Union (EU), an official at Seoul’s foreign ministry said Monday. The director-general meeting is set for Jan. 23 after the [...]
SEOUL, Mar. 9 (Korea Bizwire) — South Korean biopharmaceutical firm Samsung Bioepis Co. said Friday its biosimilar cancer drug Ontruzant has begun selling in Britain following approval from a European regulator. Global health care company MSD has begun distributing the biosimilar that references Switzerland-based Roche Holding’s Herceptin, also known as Trastuzumab, in the country, Samsung [...]
SEOUL, Aug. 1 (Korea Bizwire) — An affiliate of South Korean biopharmaceutical firm Celltrion Inc. said Tuesday that its biosimilar drug Truxima accounts for 30 percent of the Britain market. Truxima, a reference to Roche’s Mabthera, also known as Rituxan, has become a presence in the European country since its launch in April, Celltrion Healthcare [...]
SEOUL, June 27 (Korea Bizwire) – South Korea will maintain its friendly ties with Britain and the European Union on “solid” footing even after Britain leaves the world’s largest economic block, a foreign ministry official said Monday. The government will also keep its close cooperative ties with them on the diplomatic front, in particular, in [...]
SEOUL, Sept. 21 (Korea Bizwire) — A translated version of a new book by a best-selling South Korean children’s novelist will be sold in Britain, the author’s overseas agency said Monday. The British publishing company, Little, Brown Book Group, will publish Hwang Seon-mi’s “The Dog Who Dreamed of Love” in English next fall, KL Management [...]